Tear function and ocular surface changes with topical mitomycin (MMC) treatment for primary corneal intraepithelial neoplasia

Cornea

Volumn 22, Issue 7, 2003, Pages 627-639

  Dogru, Murat ^a,b   Erturk, Haluk ^a   Shimazaki, Jun ^b   Tsubota, Kazuo ^b   Gul, Murat ^c  

^a ULUDAG UNIVERSITY   (Turkey)

^b TOKYO DENTAL COLLEGE   (Japan)

^c Bartin Government Hospital   (Turkey)

Author keywords

Conjunctival impression cytology; Corneal intraepithelial neoplasia; Corneal sensitivity; Mitomycin C

Indexed keywords

MITOMYCIN C; ROSE BENGAL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONJUNCTIVA; CORNEA TUMOR; DIAGNOSTIC VALUE; DRUG EFFECT; EPITHELIUM CELL; FEMALE; FOLLOW UP; GOBLET CELL; HUMAN; IMPRESSION CYTOLOGY; LACRIMAL FLUID; MALE; MITOSIS; PRIORITY JOURNAL; RECURRENCE RISK; SCHIRMER TEST; SQUAMOUS CELL METAPLASIA; TEAR FILM;

ADMINISTRATION, TOPICAL; AGED; ANTIBIOTICS, ANTINEOPLASTIC; CELL COUNT; CONJUNCTIVA; CORNEA; CORNEAL DISEASES; EPITHELIAL CELLS; EYE NEOPLASMS; FEMALE; FLUORESCENT DYES; GOBLET CELLS; HUMANS; MALE; METAPLASIA; MIDDLE AGED; MITOMYCIN; PROSPECTIVE STUDIES; ROSE BENGAL; STAINING AND LABELING; TEARS;

EID: 0141485294     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200310000-00007     Document Type: Article

References (32)

1. Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol. 1995;39:429-450.
2. Lee GA, Williams G, Hirst LW, et al. Risk factors in the development of ocular surface epithelial dysplasia. Ophthalmology. 1994;101:360-364
3. Waring GO 3rd, Roth AM, Ekins MB. Clinical and pathological description of 17 cases of corneal intraepithelial neoplasia. Am J Ophthalmol. 1994;97:547-559.
4. Peksayar G, Soytürk MK, Demiryont M. Long term results of cryotherapy on malignant epithelial tumors of the conjunctiva. Am J Ophthalmol. 1989;107:337-340.
5. Danopoulos ED, Danopoulou IE, Liarikos SB, et al. Effect of urea treatment in malignancies of conjunctiva and cornea. Ophthalmologica. 1979;178:198-203.
6. Ferry AP, Meltzer MA, Taub RN. Immunotherapy with DNCB for recurrent squamous cell tumor of the conjunctiva. Trans Am Ophthalmol Soc. 1997;74:154-171.
7. Frucht-Pery J, Rozenman Y. Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol. 1994;117:164-168.
8. Lommatz P. Beta-ray treatment of malignant epithelial tumors of the conjunctiva. Am J Ophthalmol. 1976;81:198-206.
9. Vann RR, Karp CL. Perilesional and topical interferon alpha 2b for conjunctival and corneal neoplasia. Ophthalmology. 1999;106:91-98.
10. Yeatts RP, Engelbrecht NE, Curry CD, et al. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Ophthalmology. 2000;107:2190-2195.
11. Frucht-Pery J, Peter J. The use of mitomycin C in the treatment of primary acquired melanosis with atypia. Arch Ophthalmol. 1996;114:1261-1264.
12. Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology. 1991;98:317-321.
13. Singh G, Wilson MR, Foster CS. Long term follow-up study of mitomycin eye drops as treatment of pterygium. Ophthalmology. 1988;95:813-821.
14. Dogru M, Katakami C, Nakagawa N, et al. Impression cytology in atopic dermatitis. Ophthalmology. 1998;105:1478-1484.
15. Dogru M, Katakami C, Miyashita M, et al. Ocular surface changes after excimer laser phototherapeutic keratectomy. Ophthalmology. 2000;107:1144-1152.
16. Dogru M, Katakami C, Miyashita M, et al. Visual and tear function improvement after superficial PTK for mid-stromal corneal scarring. Eye. 2000;14:779-784.
17. Dogru M, Katakami C, Inoue M. Tear function and ocular surface changes in non-insulin dependent diabetes mellitus. Ophthalmology. 2001;108:586-592.
18. Nelson JD. Impression cytology. Cornea. 1988;7:71-81.
19. Rozenman Y, Frucht-Pery J. Treatment of conjunctival intraepithelial neoplasia with topical drops of of mitomycin C. Cornea. 2000;19:1-6.
20. Wilson MW, Hungerford JL, George SM, et al. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol. 1997;124:303-311.
21. Hayasaka S, Noda S, Yamamoto Y, et al. Postoperative instillation of low-dose mitomycin C in the treatment of primary pterygium. Am J Ophthalmol. 1988;106:715-718.
22. Rubinfeld RS, Plister RR, Stein RM. Serious complications of topical mitomycin C after pterygium surgery. Ophthalmology. 1992;99:1647-1654.
23. Singh G, Wilson MR, Foster CS. Mitomycin eye drops as adjunctive treatment for pterygia and its comparison with conjunctival autograft transplantation. Cornea. 1990;9:331-334.
24. Nolan GR, Hirst LW, Bancroft BJ. Efficacy of a training programme designed to teach cervical smear screeners to identify ocular surface squamous neoplasia using conjunctival impression cytology. Cytopathology. 1997;8:388-396.
25. Tole DM, McKelvie PA, Daniell M. Reliability of impression cytology for the diagnosis of ocular surface squamous neoplasia employing the Biopore membrane. Br J Ophthalmol 2001;85:154-158.
26. Martin XY, Safran AB. Corneal hypoesthesia. Surv Ophthalmol. 1988;33:28-40.
27. Kinoshita S, Kiorpes TC, Friend J, et al. Goblet cell density in ocular surface disease. Arch Ophthalmol. 1983;101:1284-1287.
28. Tseng SCG, Tsubota K. Important concepts for treating ocular surface and tear disorders. Am J Ophthalmol. 1997;124:825-835.
29. Tseng SH, Chen YT, Cheng HC, et al. Impression cytology study of conjunctival epithelial phenotypes on the healing ocular surface after pterygium excision. Cornea. 2001;20:244-250.
30. Nolan GR, Hirst LW, Bancroft BJ. The cytomorphology of ocular surface squamous neoplasia by using impression cytology. Cancer. 2001;93:60-67.
31. Sugar A. Who should receive MMC after pterygium? (editorial). Ophthalmology. 1992;99:1645-1646.
32. McKelvie PA, Daniell M. Impression cytology following mitomycin-C therapy for ocular surface squamous metaplasia. Br J Ophthalmol. 2001;85:1115-1119.